Infinity Pharmaceuticals, Inc. (INFI) Stock took a Leap in the Market. Here’s why
Infinity Pharmaceuticals, Inc., (INFI), is a biopharmaceutical company developing drugs for cancer patients. Its product candidate is eganelisib (IPI-549) which is orally administered. It has